GAPLINC and cancer: HEIH [40], LINC02418 [41], POU3F3 [40], GAPLINC [42], SNHG8 [43], SNHG16 [39], UFC1 [32], AFAP1-AS1 [39], BCAR4 [40], CCAT2 [39], CRNDE [44], DLX6-AS1 [32], HNF1A-AS1 [45], HOXA-AS2 [44], NNT-AS1 [41], PCA3 [44], PCAT1 [46], SBF2-AS1 [39], SNHG11 [47], SNHG14 [48], SNHG6 [43], SNHG7 [49], and SOX2-OT [41] are predicted to sponge several miRNAs (in cancer cells) to promote cancer proliferation.